Cellectar Biosciences, Inc.
NASDAQCellectar Biosciences went from a quiet short base to a lending market crisis in a single session. Short interest jumped 1,380% in one day to 6.5% of float. Cost to borrow rocketed to 150.4%. Availability has collapsed — and earnings are two days away. Short interest sat below 0.5% of float for most of April. It had been falling steadily, down 75%…
CLRB short interest plummets 42% in one week to 0.39% of float, down 75% over one month as stock rebounds 8%.
Short interest % of float, cost to borrow, utilization, and put/call ratio for CLRB are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 6 May 2026
Cellectar Biosciences went from a quiet short base to a lending market crisis in a single session. Short interest jumped 1,380% in one day to 6.5% of float. Cost to borrow rocketed to 150.4%. Availability has collapsed…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLRB — free to start on ORTEX.
Sign up for free →Open CLRB on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CLRB data →